Indonesian Citizen, domiciled in Bandung. He was born in Pangkalpinang on 23 September 1962. He obtained the degree of Bachelor of Pharmacy, Bandung Institute of Technology in 1988 and the degree of Apothecary in 1989 at the same alma mater and continued his study by taking the Master of Operations Management program at the Padjadjaran University and obtained the Master’s degree in 2005. The legal basis for appointment as Senior Executive Vice President (SEVP) Manufacturing is pursuant to Decree of the Board of Directors of PT Bio Farma (Persero) Number: KEP-05779/DIR/IX/2019 dated 16 September 2019. Previously serving as Director of Manufacturing for the first period pursuant to Decree of the Minister of SOE Number: SK-221/MBU/2013 dated 12 April 2013. In 10 July 2017, the Ministry of SOE as a shareholder issued a Decree Number: SK-127/MBU/07/2017 stipulated Juliman as Acting President Director of Bio Farma until the appointment of definitive President Director, i.e. 23 January 2018. He was reappointed as Director of Manufacturing for the second period pursuant to Decree of the Minister of SOE Number: SK – 101/MBU/04/2018 dated 20 April 2018. He previously held various structural and strategic positions as Head of Poliomyelitis and Measles Vaccine Support Department, Head of Measles Vaccine Manufacturing Department, Head of Engineering and Maintenance Division, Head of Export Marketing Division and Head of Logistics Division. His experience in the field of vaccine manufacturing and Good Manufacturing Practices (GMP) often made him an informant in seminar, interview and audience events. He is also often involved in various international level activities, namely being active as a Trainer in the WHO Global Training Network (GTN) on Quality Assurance of Live Attenuated Poliomyelitis and Measles Vaccines and part of the Indonesian delegates in attending the World Health Assembly Forum organized by the World Health Organization (WHO). He also actively attends the Annual General Meeting held by the DCVMN (Developing Countries Vaccines Manufacturer Network), i.e. developing countries vaccines manufacturer collaboration organization. He currently serves as member of the Alternate Board of GAVI (Global Alliance for Vaccine Immunization) representing the DCVMN Organization to attend the GAVI Board Meeting regularly held three times a year to discuss and decide on the policies taken by the GAVI Board related to the Global Immunization program. Not affiliated with with other members of the Board of Directors, members of the Board of Commissioners or the shareholders.

Indonesian Citizen, domiciled in Jakarta. He was born in Tanjung Pinang, on 18 December 1965. Graduated as a Bachelor of Law from the Jakarta Islamic University (1989) and a Master of Law from the University of Indonesia (1998). The legal basis for appointment as Senior Executive Vice President (SEVP) Legal and Compliance is pursuant to Decree of the Board of Directors of PT Bio Farma (Persero) Number: KEP-05777/DIR/IX/2019 dated 16 September 2019. Joined PT Bio Farma (Persero) in 2017 and serving as Director of HR and General Affairs pursuant to Decree of the Minister of State Owned Enterprises number SK-131/MBU/07/2017 dated 14 July 2017. He previously served as Director of HR and Law at PT Pelindo II, from 16 May 2016 until 14 July 2017. More than twenty years in service at one of the State Owned Enterprises, i.e. PT Bank Negara Indonesia (Persero), he also served as Head of Legal Division (2011 - 2015) Jakarta Kota Regional Head (2015 - 2016), SEVP Network and Services (2016) and various other strategic positions. For the last several years, he has been entrusted with a functional position at several supervisory committees. Not affiliated with with other members of the Board of Directors, members of the Board of Commissioners or the shareholders.

Indonesian Citizen, domiciled in Bandung.  He was born in Bloomington, Indiana, USA, on 5 September 1963, obtained the Bachelor of Pharmacy degree from the Bandung Institute of Technology in 1988, and obtained the Master of Operations Management degree from the Padjadjaran University in 2005. The legal basis for appointment as Senior Executive Vice President (SEVP) Research and Development is pursuant to Decree of the Board of Directors of PT Bio Farma (Persero) Number: KEP-05778/DIR/IX/2019 dated 16 September 2019. Previously serving as Director of Planning and Development pursuant to Decree of the Minister of SOE Number: SK – 101/MBU/04/2018. He has dedicated himself to Bio Farma since 1989 by occupying various strategic positions as Head of Business Planning and Strategy Division, Head of Quality Assurance Division; Apothecary In Charge of Quality, Head of Bacteria Vaccine Division and Head of Pharmaceutical Product Division. His experience in research made him involved in various international activities, such as the Developing Countries Vaccine Manufacturers’ Network (DCVMN), World Health Organisation (WHO) dan International Society for Pharmaceutical Engineering (ISPE). In addition, he is also active as an informant in various domestic and overseas activities, namely the Annual General Meeting of Developing Countries Vaccine Manufacturers’ Network (DCVMN), Rio de Janeiro, Brazil; World Health Organization (WHO) QC course on Hib vaccine, NVI, The Netherlands; ISPE Indonesian Affiliate annual conference 2012, Jakarta;  National Vaccine Research Forum, Jakarta; Rotavirus symposium, Bangkok, Thailand; Proteomic Avian Flu Vaccine Seminar, Avian Influenza Research Center (AIRC), Airlangga Univ, Surabaya; WHO briefing for manufacturers WHO prequalification programme” Beijing, China; Global Health Regulatory Meeting on PDPs organized by PATH, Hanoi, Vietnam, etc. Not affiliated with with other members of the Board of Directors, members of the Board of Commissioners or the shareholders.

Indonesian Citizen, born in Selayar, South Sulawesi, Indonesia, 7 March 1949. As of 31 December 2020, his age is 79 years old. Attended education at several domestic and overseas universities Faculty of Economics of Hasanudin University, Makassar, Master of Business Administration Program, University of New York Buffalo, Doctor, Multidisciplinary Science, University of Gadjah Mada. Previously occupying several important positions at several large companies, including SOE, such as President Commissioner of PT Telekom Komunikasi (2004 - 2010) and President Commissioner of Pertamina (2010 - 2019). He also occupied several prominent positions at the government, such as serving as Minister of SOE Utilization in the Development Cabinet VII and Development Reformation Cabinet. The legal basis for appointment of President Commissioner of Bio Farma is pursuant to the copy of Decree of the Minister of State Owned Enterprises as the General Meeting of Shareholders of the Company (Persero) PT Bio Farma Number SK-149/MUB/05/2021 concerning Dismissal and Appointment of Members of the Board of Commissioners of the Company (Persero) PT Bio Farma dated 7 May 2021. Not affiliated with with other members of the Board of Directors, members of the Board of Commissioners or the shareholders.

An Indonesian citizen, domiciled in Jakarta, she was born in Jakarta, on September 24. She completed her studies at the Faculty of Dentistry (FKG) University of Indonesia in 1988, and earned her Masters in Public Health from the University of Indonesia in 2005. 

The legal basis for her appointment as the Board of Commissioners of PT Bio Farma (Persero) is based on the Decree of the Minister of SOE NUMBER: SK-70/MBU/03/2022 dated March 8, 2022. She serve as Director General of Health Personnel of the Indonesian Ministry of Health in 2021 has held several other strategic positions at the Ministry of Health, including Acting Director General of Pharmacy and Equipment Health, and Secretary of the Directorate General of Pharmaceuticals and Medical Devices since 2018, Director of Assessment of Medical Devices and Household Health Supplies in 2016, and Director of Production and Distribution of Medical Devices in 2012.

She is also active in several National Cooperation activities including Member of the Working Group Medical Device Industry Development 2018 – now, Member of the Expert Team for Assessment of Medical Devices and PKRT 2018 – now.

International Cooperation includes Steering Committee, WHO-SEARN (South East Asia Regulatory Network) | 2016 – present and Indonesia Head of Delegation in APEC-RHSC 2015 – 2019.

Indonesian citizen, born on December 8, 1967. Graduated as a Bachelor of Economics and Agriculture from Bogor Agricultural University (IPB) in 1991. Obtained a Master's Degree in Planning and Public Policy from the University of Indonesia in 2000. Then obtained a Doctoral degree in the field of Agricultural Economics, from IPB in 2012. The legal basis for the appointment as the Board of Commissioners of PT Bio Farma (Persero) is based on the Decree of the Minister of BUMN Number: SK-323/MBU/10/2021 concerning Dismissal and Appointment of Members of the Board of Commissioners of the Company (Persero) PT Bio Farma Date October 1, 2021. Currently he is still serving as Widyaswara Utama BAPPENAS since September 2021. He has no affiliation with other members of the Board of Directors, members of the Board of Commissioners or shareholders.

Indonesian Citizen, domiciled in Jakarta. Born in Singaraja, on 17 August 1965. As of 31 December 2020, his age is 55 years old. Graduated as Diploma III, National College of Accounting, Jakarta (1987) and Bachelor of Economics, Jakarta Islamic University (1995), finished the Master of Science in Finance, University of Colorado at Denver, USA in 2001. The legal basis for appointment as Commissioner of Bio Farma is pursuant to Decree of the Minister of SOE Number: SK – 102/MBU/04/2018 dated 20 April 2018. He currently serves as Director of Budgeting Rule Harmonization, Directorate of Budgeting Rule Harmonization, Directorate General of Budget since November 2015 - current. He previously served as Acting Director of Budgeting Rule Harmonization, Directorate of Budgeting Rule Harmonization, Directorate General of Budget from September 2014 - November 2015, and served as Head of Sub Directorate of Budgeting System Development, Directorate of Budgeting System, Directorate General of Budget, 2008 - 2011. At the start of his career, he served as Implementation Officer at the Directorate of Miscellaneous Budget, Directorate General of Budget, 1988 - 1990 and as Implementation Coordinator at the Directorate of Miscellaneous Budget, Directorate General of Budget, 1990 - 1996. Not affiliated with other members of the Board of Directors and members of the Board of Directors or the shareholders.

Prof. Dr. Ahmad M. Ramli,S.H.,M.H.,FCB.Arb. Born in Bandung on 4 July 1961, is a Professor of Cyber Law and Intellectual Property Law at the Padjadjaran University. He currently serves as Director General of Post and Informatics Operations, Ministry of Communications and Informatics of the Republic of Indonesia. Previous positions include the Director General of Intellectual Property, Head of National Law Development Agency (BPHN), and Acting Director General of Law and Legislation, Ministry of Law and Human Rights of the Republic of Indonesia. In the corporate world, he served as Commissioner at the SOE. In the Legislation Field, he was trusted to become the Government Team Chairman in discussing various Bills together with the House of Representatives of the Republic of Indonesia, such as: Copyright Bill, Trademark Bill, Patent Bill, Public Information Disclosure Bill, Money Laundering Bill, Information and Electronic Transaction Bill (as Deputy Chairman) etc., all of which were promulgated. In his Profession, he currently serves as member of the Expert Council of the Indonesian Association of Bachelor of Law (ISHI). He pursued higher education by finishing his S1, S2 programs and the Jurisprudence Doctoral Program (graduated cum laude) from the Padjadjaran University. Attended the Visiting Scholar Program at the University of California Berkeley, USA, and Certificate Program on Intellectual Property at the Japan Patent Office, Tokyo. For his commendable service to the country, in 2019 he was awarded the Satya Lencana Wirakarya by President Joko Widodo. In addition, he also received the Satya Lencana Karya Satya X, XX, and XXX Year award from the President of the Republic of Indonesia, and Satya Karya Bakti Pendidikan from the Rector of Padjadjaran University. At the Padjadjaran University, he served as Dead at the Faculty of Law. When he was a college student, he was recorded as Chairman of the Student Senate at the Faculty of Law, Padjadjaran University, and elected as First Exemplary student of the Padjadjaran University, and received the national award of Exemplary student from the Minister of Education and Culture of the Republic of Indonesia. Not affiliated with other members of the Board of Directors and members of the Board of Directors or the shareholders.

Indonesian Citizen, born in Surabaya, 23 December 1952. As of 31 December 2020, his age is 68 years old. Finished S1 education at the Faculty of Medicines, Airlangga University in 1982. Continued his education to the Oxford University, Oxford England from 1991 - 1992. Later in 1994, finished his education as Neurologist at the Faculty of Medicines, University of Indonesia. Later in 2003, finished his education as Consultant in the field of Neurology. He occupied several strategic positions, namely as Member of the Board of Commissioners of PT Indofarma, Tbk from 2018 - 2019. Member of the Board of Commissioners of PT Surveyor Carbon Consulting from 2011 - 2015, Member of the Board of Commissioners of Sanglah Bali Hospital from 2011 - 2016, and also served as Member of the Board of Commissioners of PT Bio Farma (Persero) from 2012 - 2016.  The legal basis for appointment of President Commissioner of Bio Farma is pursuant to the Copy of Decree of the Minister of State Owned Enterprises As the General Meeting of Shareholders of the Company (Persero) of PT Bio Farma Number: SK-149/MUB/05/2021 concerning Dismissal and Appointment of Members of the Board of Commissioners of the Company (Persero) of PT Bio Farma dated 7 May 2021. Not affiliated with other members of the Board of Directors and members of the Board of Directors or the shareholders.